Literature DB >> 16316882

Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome.

Wendy M Gonsalkorale1.   

Abstract

This article describes the particular approach of using hypnosis as an adjunct to treating irritable bowel syndrome, developed within the Department of Medicine at the University Hospital of South Manchester, UK, since the 1980s. Patients receive up to 12 sessions over a 3-month period, and the majority of patients achieve marked improvement in symptoms and quality of life, an effect that is usually sustained. The therapy has a "gut-directed" framework that aims to teach patients the necessary hypnotic skills to control gut function and reduce symptoms, such as hand warmth on the abdomen and imagery. Other interventions based on particular lifestyle and psychological factors commonly found to influence symptoms are also included as appropriate for the individual patient.

Entities:  

Mesh:

Year:  2006        PMID: 16316882     DOI: 10.1080/00207140500323030

Source DB:  PubMed          Journal:  Int J Clin Exp Hypn        ISSN: 0020-7144


  12 in total

Review 1.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

2.  Body awareness therapy: a new strategy for relief of symptoms in irritable bowel syndrome patients.

Authors:  E M Eriksson; I E Möller; R H Söderberg; H T Eriksson; G K Kurlberg
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

3.  A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).

Authors:  Carla E Flik; Yanda R van Rood; Wijnand Laan; André Jpm Smout; Bas Lam Weusten; Peter J Whorwell; Niek J de Wit
Journal:  BMC Gastroenterol       Date:  2011-12-20       Impact factor: 3.067

4.  Sensitivity and specificity of hypnosis effects on gastric myoelectrical activity.

Authors:  Paul Enck; Jochen Hefner; Beate M Herbert; Nazar Mazurak; Katja Weimer; Eric R Muth; Stephan Zipfel; Ute Martens
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

5.  Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases.

Authors:  Sarah Ballou; Laurie Keefer
Journal:  Clin Transl Gastroenterol       Date:  2017-01-19       Impact factor: 4.488

6.  The structure of resilience in irritable bowel syndrome and its improvement through hypnotherapy: Cross-sectional and prospective longitudinal data.

Authors:  Johannes Peter; Ulrich S Tran; Maria Michalski; Gabriele Moser
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

Review 7.  Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol.

Authors:  Dipesh H Vasant; Peter J Whorwell
Journal:  Neurogastroenterol Motil       Date:  2019-02-27       Impact factor: 3.598

8.  Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.

Authors:  Daniël R Hoekman; Arine M Vlieger; Pieter C Stokkers; Nofel Mahhmod; Svend Rietdijk; Nanne K de Boer; Tim G de Meij; Carla Frankenhuis; Geert R D'Haens; Marc A Benninga
Journal:  J Crohns Colitis       Date:  2021-07-05       Impact factor: 9.071

9.  Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists.

Authors:  Juliette M T M Rutten; Arine M Vlieger; Carla Frankenhuis; Elvira K George; Michael Groeneweg; Obbe F Norbruis; Walther Tjon a Ten; Herbert Van Wering; Marcel G W Dijkgraaf; Maruschka P Merkus; Marc A Benninga
Journal:  BMC Pediatr       Date:  2014-06-04       Impact factor: 2.125

10.  Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.

Authors:  Johannes Peter; Camille Fournier; Bettina Keip; Nina Rittershaus; Nicola Stephanou-Rieser; Marija Durdevic; Clemens Dejaco; Maria Michalski; Gabriele Moser
Journal:  Int J Mol Sci       Date:  2018-11-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.